retatrutide phase 2 trial obesity nejm 2023 triple agonist ๐จBreaking: Retatrutide's first 3 T2D data just dropped. โธ A1C: โ2.0% at 40 weeks โธ Weight: โ36.6 lbs (โ16.8%) at 12 mg โธ No weight loss plateau โ curve still descending Retatrutide vs Tirzepatide Compared |
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 5 - Aug 10




























